HDAC10 and cancer: This presents a unique therapeutic opportunity where targeting HDAC10 could potentially enhance cancer cell vulnerability by disrupting their survival mechanisms, particularly in cancers that rely on autophagy for survival (Oehme et al., 2013; Hai et al., 2021).